These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23342613)

  • 21. [Effect of cycloferon on tonsils microflora in often ill children].
    lialikov SA; Bedin PG; Ermak SIu; Ianovich RV
    Eksp Klin Farmakol; 2013; 76(3):31-4. PubMed ID: 23767101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [USING INTERFERON INDUCTORS IN THERAPY OF PRE-SCHOOL-AGE PATIENTS WITH REACTIVATED EPSTEIN - BARR VIRUS INFECTION.].
    Khmilevakaya SA; Zaitseva IA
    Eksp Klin Farmakol; 2016; 79(6):24-29. PubMed ID: 29782751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative analysis of the effectiveness of antiviral therapy of children with infectious mononucleosis].
    Baranova IP; Kurmaeva DIu
    Eksp Klin Farmakol; 2013; 76(8):47-9. PubMed ID: 24228491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protective effect of cycloferon in experimental influenza].
    Sukhinin VP; Zarubaev VV; Platonov VG; Kovalenko AL; Ershov FI
    Vopr Virusol; 2000; 45(5):26-30. PubMed ID: 11107650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testicular nodules in a 16-year-old boy.
    Friedman BC; Banai M; Friedman B; Neheman A; Ephros M
    Pediatr Infect Dis J; 2009 Feb; 28(2):168, 171-2. PubMed ID: 19177033
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
    Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
    Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brucella orchitis: a rare cause of testicular enlargement.
    Reisman EM; Colquitt LA; Childers J; Preminger GM
    J Urol; 1990 Apr; 143(4):821-2. PubMed ID: 2313817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of childhood Brucellosis with neurological involvement and epididymo-orchitis.
    Kanık-Yüksek S; Gülhan B; Ozkaya-Parlakay A; Tezer H
    J Infect Dev Ctries; 2014 Dec; 8(12):1636-8. PubMed ID: 25500664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cycloferon in treating duodenal ulcers in rats].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kuznetsova NN; Anikin VB; arinenko RIu; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2001; 64(6):41-4. PubMed ID: 11871237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy].
    Romantsov MG; Kovalenko SN; Sologub TV; Anikina OV
    Antibiot Khimioter; 2008; 53(3-4):18-22. PubMed ID: 18942421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of immunomodulator cycloferon on quality of life and psychoemotional state of patients with chronic active brucellosis subjected to complex pharmacotherapy].
    Smagina AN; Shul'diakov AA
    Eksp Klin Farmakol; 2011; 74(2):39-43. PubMed ID: 21476285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of chlamydial infection in chronic prostatitis].
    Shperling NV; Vengerovskiĭ AI; Shperling IA; Mironiuk DV; Bezmenova MA; Kalaĭda EV
    Urologiia; 2011; (4):45, 47-9. PubMed ID: 22066242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimentally induced orchitis associated with Arcanobacterium pyogenes: clinical, ultrasonographic, seminological and pathological features.
    Gouletsou PG; Fthenakis GC; Cripps PJ; Papaioannou N; Lainas T; Psalla D; Amiridis GS
    Theriogenology; 2004 Oct; 62(7):1307-28. PubMed ID: 15325557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cycloferon efficacy in the treatment of acute respiratory tract viral infection and influenza during the morbidity outbreak in 2009-2010].
    Romantsov MG; Golofeevskiĭ SV
    Antibiot Khimioter; 2010; 55(1-2):30-5. PubMed ID: 20583555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)].
    Sologub TV; Shul'diakov AA; Romantsov MG; Zhekalov AN; Petlenko SV; Erofeeva MK; Maksakova VL; Isakov VA; Zarubaev VV; Gatsan VV; Kovalenko AL
    Antibiot Khimioter; 2009; 54(7-8):30-2, 34-6. PubMed ID: 20201401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of immunotropic preparation cycloferon and phytopreparations of Cynara scolimus L. on blood cytokines profile of the patients with chronic viral hepatitis C in medical rehabilitation period].
    Frolov VM; Sotskaia IaA; Kruglova OV
    Lik Sprava; 2012; (1-2):102-7. PubMed ID: 23035608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Estimation of clinical-pathogenetic efficiency of reamberin and cycloferon application in patients with the severe form of acute tonsillitis].
    Frolov VM; Tereshkin VA; Sotskaia IaA; Peresadin NA; Kruglova OV
    Lik Sprava; 2013 Mar; (2):124-9. PubMed ID: 24605622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases].
    Lialikov SA; Romantsov MG; Bedin PG; Ermak SIu
    Antibiot Khimioter; 2012; 57(11-12):26-32. PubMed ID: 23700934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cycloferon administration in chronic pyelonephritis: changes in interferon status].
    Kudriashova IP; Ospel'nikova TP; Ershov FI
    Ter Arkh; 2011; 83(6):33-5. PubMed ID: 21786573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.